Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
4
×
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
4
×
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
4
×
texas top stories
wisconsin blog main
wisconsin top stories
allergan
clinical trials
eli lilly
fda
bristol-myers squibb
genentech
glaxosmithkline
ipo
medical device
10x genomics
abbvie
adaptive biotechnologies
What
drugs
4
×
bio
drug
fda
new
roundup
won
appetite
approval
arguments
august
big
biotech
black
bread
busy
butter
buyout
cancer
cash
cholesterol
class
commercialized
companies
competitors
days
decades
decisions
devices
diabetes
diamond’s
eli
expensive
faces
financial
foe
giant
grabbed
hasn’t
healthcare
Language
unset
Current search:
amgen
×
" detroit blog main "
×
drugs
×
" texas blog main "
×
@xconomy.com
5 years ago
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)
@xconomy.com
5 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More